These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 18851701)
1. The COXIB experience: a look in the rearview mirror. Marnett LJ Annu Rev Pharmacol Toxicol; 2009; 49():265-90. PubMed ID: 18851701 [TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory drugs in the 21st century. Rainsford KD Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044 [TBL] [Abstract][Full Text] [Related]
4. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs. Fiorucci S; Distrutti E Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233 [TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk. Carnevali S; Buccellati C; Bolego C; Bertinaria M; Rovati GE; Sala A Curr Med Chem; 2017; 24(30):3218-3230. PubMed ID: 28571535 [TBL] [Abstract][Full Text] [Related]
7. The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction. Martelli A; Testai L; Anzini M; Cappelli A; Di Capua A; Biava M; Poce G; Consalvi S; Giordani A; Caselli G; Rovati L; Ghelardini C; Patrignani P; Sautebin L; Breschi MC; Calderone V Pharmacol Res; 2013 Dec; 78():1-9. PubMed ID: 24083950 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of selective COX-2 inhibitors. Capone ML; Tacconelli S; Sciulli MG; Patrignani P Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704 [TBL] [Abstract][Full Text] [Related]
16. COX-2 selective inhibitors in the treatment of osteoarthritis. Laine L; White WB; Rostom A; Hochberg M Semin Arthritis Rheum; 2008 Dec; 38(3):165-87. PubMed ID: 18177922 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966 [TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibition: insight into non-COX-2 pharmacological effect of some coxibs. Dogné JM; Thiry A; Supuran CT Curr Pharm Des; 2008; 14(7):679-84. PubMed ID: 18336314 [TBL] [Abstract][Full Text] [Related]
19. Dual acting anti-inflammatory drugs: a reappraisal. Bertolini A; Ottani A; Sandrini M Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348 [TBL] [Abstract][Full Text] [Related]
20. [Trends in nonsteroidal anti-inflammatory drug development and application]. Miedzybrodzki R Postepy Hig Med Dosw (Online); 2004; 58():438-48. PubMed ID: 15577751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]